We are not entirely able to understand, assess, and modulate the functioning of the immune
system in clinical situations that lead to a systemic inflammatory response. In the search for …

Abstract While The World Health Organization (WHO) has announced that COVID-19 is no
longer a public health emergency of international concern (PHEIC), the risk of reinfection …

Mesenchymal stromal cells (MSC) have immunomodulatory and tissue-regenerative
properties and have shown promising results in acute respiratory distress syndrome (ARDS) …

Mesenchymal Stem Cells (MSCs) are being investigated as a treatment for a novel viral
disease owing to their immunomodulatory, anti-inflammatory, tissue repair and regeneration …

Cytokine release syndrome (CRS) is an acute systemic inflammatory reaction in which
hyperactivated immune cells suddenly release a large amount of cytokines, leading to …

The risks of severe ionizing radiation exposure are increasing due to the involvement of
nuclear powers in combat operations, the increasing use of nuclear power, and the …

Abstract Background The STROMA-CoV-2 study was a French phase 2b, multicenter,
double-blind, randomized, placebo-controlled clinical trial that did not identify a significant …

Anal cytology in immunocompetent patients with high-grade in Role of physical activity in
cancer survival and recurrence: Bilateral Parasymphyseal Osteoma Requirement for object …

Mesenchymal Stem Cells (MSCs) have antimicrobial, anti-inflammatory, immunomodulatory,
and regenerative potentials. Additionally, utilization of MSCs in the clinical arena has been …

Mesenchymal stromal cells (MSCs) have immunomodulatory and anti-inflammatory effects,
can be differentiated to multiple cell lineages and can induce pro-reparative changes in …